Christine T. Ekdahl
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Christine T. Ekdahl has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
Deepti Chugh
Division of Clinical Neurophysiology, Sweden; Lund Epilepsy Center, Department of Clinical Sciences, Lund University, Sweden
9 shared publicationsUna Avdic
Division of Clinical Neurophysiology and Department of Clinical Sciences, Lund University, Sweden
8 shared publicationsMatilda Ahl
Inflammation and Stem Cell Therapy Group, Division of Clinical Neurophysiology, Department of Clinical Sciences, Lund University, Lund, Sweden; Lund Epilepsy Center, Department of Clinical Sciences, Lund University, Lund, Sweden
7 shared publications- Idrish Ali
Department of Neuroscience, School of Translational Medicine Monash University Melbourne Victoria Australia
5 shared publications Jenny Wickham
Department of Clinical Sciences, Lund Epilepsy Centre Lund University Lund Sweden
3 shared publications- Alejandra Sierra
A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland
2 shared publications
Latest Publications
- Open Access
- 4 July 2026
- Published by Wiley in Epilepsia Open
- Vol. 11 (5) , 1437-1449
Rest‐activity patterns across development in two mouse models of autism and epilepsy
Objective: Sleep disturbances are common in individuals with autism spectrum disorder (ASD) and epilepsy and are increasingly recognized as comorbidities that affect disease severity and quality of life. This study investigated rest‐activity patterns across development in two genetic mouse models relevant to ASD and epilepsy: synapsin 2 (Syn2) and contactin‐associated protein‐like 2 (Cntnap2) knockout (KO) mice, in which epileptic seizures typically emerge at 2–3 months and around 6 months of age, respectively. Methods: Actigraphy, a noninvasive method for monitoring rest‐locomotor activity patterns, was performed in male and female Syn2 KO ( n = 25), Cntnap2 KO ( n = 32), and wild type ( n = 31) mice at 1–2, 3–5, and 5–7 months of age. Recordings consisted of 72 h of continuous monitoring during a 12‐h light/12‐h dark cycle following a 12‐h acclimatization period. Infrared sensors at two cage heights detected both subtle and prominent movements, allowing analysis of age‐dependent rest–activity rhythms. Results: Across all genotypes and ages, mice showed higher activity during the dark phase, confirming the light phase as the preferred rest/sleep period. Adolescent (1–2 months) Syn2 KO mice exhibited normal rest–activity patterns, whereas adult (3–5 months) Syn2 KO mice displayed increased activity during the dark phase. In contrast, no robust age‐dependent rest‐activity alterations were detected in either adolescent or adult Cntnap2 KO mice after correction for multiple comparisons. Significance: Adult Syn2 KO mice exhibit hyperactivity during their preferred wake period, coinciding with the age range associated with seizure emergence in this model, whereas Cntnap2 KO mice do not exhibit robust developmental alterations in rest‐activity behavior. These findings highlight genotype‐ and age‐dependent differences in mouse models relevant to ASD and epilepsy. Plain Language Summary: Sleep problems are common in people with autism and epilepsy, but why they occur is still unclear. In this study, we examined rest‐activity patterns in mice carrying two different genes linked to autism and epilepsy using a noninvasive method that tracks movement over time. We found that mice lacking the Syn2 gene developed hyperactivity in adulthood, during a life stage associated with seizures in this model, whereas mice lacking the Cntnap2 gene did not show consistent changes in rest‐activity patterns across development. These findings suggest that activity patterns in genetic models of autism and epilepsy depend on age and genetic background.
- 4 July 2026
- Published by Wiley in Epilepsia Open
- Vol. 11 (5) , 1437-1449
Open AccessRest‐activity patterns across development in two mouse models of autism and epilepsy
Objective: Sleep disturbances are common in individuals with autism spectrum disorder (ASD) and epilepsy and are increasingly recognized as comorbidities that affect disease severity and quality of life. This study investigated rest‐activity patterns across development in two genetic mouse models relevant to ASD and epilepsy: synapsin 2 (Syn2) and contactin‐associated protein‐like 2 (Cntnap2) knockout (KO) mice, in which epileptic seizures typically emerge at 2–3 months and around 6 months of age, respectively. Methods: Actigraphy, a noninvasive method for monitoring rest‐locomotor activity patterns, was performed in male and female Syn2 KO ( n = 25), Cntnap2 KO ( n = 32), and wild type ( n = 31) mice at 1–2, 3–5, and 5–7 months of age. Recordings consisted of 72 h of continuous monitoring during a 12‐h light/12‐h dark cycle following a 12‐h acclimatization period. Infrared sensors at two cage heights detected both subtle and prominent movements, allowing analysis of age‐dependent rest–activity rhythms. Results: Across all genotypes and ages, mice showed higher activity during the dark phase, confirming the light phase as the preferred rest/sleep period. Adolescent (1–2 months) Syn2 KO mice exhibited normal rest–activity patterns, whereas adult (3–5 months) Syn2 KO mice displayed increased activity during the dark phase. In contrast, no robust age‐dependent rest‐activity alterations were detected in either adolescent or adult Cntnap2 KO mice after correction for multiple comparisons. Significance: Adult Syn2 KO mice exhibit hyperactivity during their preferred wake period, coinciding with the age range associated with seizure emergence in this model, whereas Cntnap2 KO mice do not exhibit robust developmental alterations in rest‐activity behavior. These findings highlight genotype‐ and age‐dependent differences in mouse models relevant to ASD and epilepsy. Plain Language Summary: Sleep problems are common in people with autism and epilepsy, but why they occur is still unclear. In this study, we examined rest‐activity patterns in mice carrying two different genes linked to autism and epilepsy using a noninvasive method that tracks movement over time. We found that mice lacking the Syn2 gene developed hyperactivity in adulthood, during a life stage associated with seizures in this model, whereas mice lacking the Cntnap2 gene did not show consistent changes in rest‐activity patterns across development. These findings suggest that activity patterns in genetic models of autism and epilepsy depend on age and genetic background.
- Open Access
- 28 May 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (11) , 1502
Iterative Adaptations in a Physical Activity Program for Children with Autism: A Feasibility and Implementation Study
Background: Children and adolescents with autism spectrum disorder (ASD) are generally more sedentary and engage less in physical activity (PA) than their peers. Despite increasing evidence of benefits, practical guidance on implementing adapted PA programs in real-world settings remains limited. This study aimed to document iterative adaptations, implementation processes, and participant experiences in a structured PA intervention for children with ASD. Methods: Nineteen children aged 10–14 years with ASD participated in an adapted PA intervention delivered across three cohorts. The program was progressively modified based on observed barriers and participant feedback. Post-intervention conversations with participants and/or parents were used to assess feasibility and experiences. Results: Most participants trained on-site in small groups and were predominantly boys, many with comorbid ADHD/ADD. Baseline engagement in organized PA was low. Adaptations included adjustments to session structure, group size, instructor-to-participant ratio, and activity content to enhance predictability and autonomy. Individual tailoring and flexible delivery were essential to accommodate neurodevelopmental diversity and fluctuating motivation. Post-intervention feedback suggested generally positive acceptability, while findings should be interpreted descriptively. Conclusions: This study provides preliminary, practice-based insights into how structured PA programs may be iteratively adapted for children with ASD in a supportive clinical context. The findings highlight practical considerations for implementing adapted PA in clinical and community settings.
- 28 May 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (11) , 1502
Open AccessIterative Adaptations in a Physical Activity Program for Children with Autism: A Feasibility and Implementation Study
Background: Children and adolescents with autism spectrum disorder (ASD) are generally more sedentary and engage less in physical activity (PA) than their peers. Despite increasing evidence of benefits, practical guidance on implementing adapted PA programs in real-world settings remains limited. This study aimed to document iterative adaptations, implementation processes, and participant experiences in a structured PA intervention for children with ASD. Methods: Nineteen children aged 10–14 years with ASD participated in an adapted PA intervention delivered across three cohorts. The program was progressively modified based on observed barriers and participant feedback. Post-intervention conversations with participants and/or parents were used to assess feasibility and experiences. Results: Most participants trained on-site in small groups and were predominantly boys, many with comorbid ADHD/ADD. Baseline engagement in organized PA was low. Adaptations included adjustments to session structure, group size, instructor-to-participant ratio, and activity content to enhance predictability and autonomy. Individual tailoring and flexible delivery were essential to accommodate neurodevelopmental diversity and fluctuating motivation. Post-intervention feedback suggested generally positive acceptability, while findings should be interpreted descriptively. Conclusions: This study provides preliminary, practice-based insights into how structured PA programs may be iteratively adapted for children with ASD in a supportive clinical context. The findings highlight practical considerations for implementing adapted PA in clinical and community settings.
- Open Access
- 16 March 2026
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 16, 1726809
Improved executive function and sleep quality in preteens with high-functioning autism following a structured physical activity program
Purpose: Children with autism spectrum disorder (ASD) frequently exhibit atypical cognitive profiles, sensory processing challenges, sleep disturbances, and co-occurring psychiatric and somatic conditions. This exploratory prospective study, with a single-arm pre-post design, investigated the effects of a 10-12 weeks structured physical activity program on psychological symptoms, cognitive function, and sleep in children aged 10–14 years with high-functioning ASD. Methods: Pre- and post-intervention assessments included parent-reported questionnaires, computerized cognitive testing using Cambridge Neuropsychological Test Automated Battery (CANTAB), and actigraphy-based sleep-wake monitoring. Results: Sixteen children completed the intervention (n = 12 boys; median age 11.5 years). Following the intervention, parents reported improvements in executive functioning as measured by the Behavior Rating Inventory of Executive Function, and in sensory processing as assessed by the Child Sensory Profile. Objective cognitive testing indicated tentative improvements in executive functioning, particularly in planning and problem-solving, on the Stockings of Cambridge (SOC) task in CANTAB. Actigraphy data indicated improved sleep quality, reflected by a reduced fragmentation index. Conclusion: A structured physical activity program may improve executive functioning (as perceived by parents and supported by objective testing), enhance sensory processing, and improve sleep quality in children with high-functioning ASD who are not regularly physically active.
- 16 March 2026
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 16, 1726809
Open AccessImproved executive function and sleep quality in preteens with high-functioning autism following a structured physical activity program
Purpose: Children with autism spectrum disorder (ASD) frequently exhibit atypical cognitive profiles, sensory processing challenges, sleep disturbances, and co-occurring psychiatric and somatic conditions. This exploratory prospective study, with a single-arm pre-post design, investigated the effects of a 10-12 weeks structured physical activity program on psychological symptoms, cognitive function, and sleep in children aged 10–14 years with high-functioning ASD. Methods: Pre- and post-intervention assessments included parent-reported questionnaires, computerized cognitive testing using Cambridge Neuropsychological Test Automated Battery (CANTAB), and actigraphy-based sleep-wake monitoring. Results: Sixteen children completed the intervention (n = 12 boys; median age 11.5 years). Following the intervention, parents reported improvements in executive functioning as measured by the Behavior Rating Inventory of Executive Function, and in sensory processing as assessed by the Child Sensory Profile. Objective cognitive testing indicated tentative improvements in executive functioning, particularly in planning and problem-solving, on the Stockings of Cambridge (SOC) task in CANTAB. Actigraphy data indicated improved sleep quality, reflected by a reduced fragmentation index. Conclusion: A structured physical activity program may improve executive functioning (as perceived by parents and supported by objective testing), enhance sensory processing, and improve sleep quality in children with high-functioning ASD who are not regularly physically active.
- Open Access
- 5 January 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 16, 1720712
Immune biomarkers for epilepsy in autism: indications of cytokine alterations in an exploratory cross-sectional pediatric study
Background: Children with autism spectrum disorder (ASD) are at increased risk of epilepsy (EP), but distinguishing epileptic seizures from ASD-associated behavior remains a clinical challenge. Although previous studies have reported changes in peripheral immune markers in adults with EP, it remains unclear whether similar immune signatures are present in pediatric patients with both ASD and EP, and more pronounced than in children with ASD alone. Methods: We conducted an exploratory, prospective, cross-sectional study of children aged 9–14 years with mild ASD, with or without EP, recruited from outpatient settings. Peripheral blood samples were analyzed by enzyme-linked immunosorbent assay for 23 immune proteins and by flow cytometry for leukocyte population counts. Analyses included t-tests / Mann–Whitney U-tests, post hoc tests for multiple comparisons, and effect size / power analyses. Results: A total of 30 children were included, n = 21 with primarily mild ASD and n = 9 with mild ASD and EP. The epilepsy cases consisted of children with generalized seizures or self-limited epilepsy with centrotemporal spikes. Three immune proteins, Interleukin (IL)-12p70, IL-13 and IL-1β, were significantly increased in the ASD + EP group compared to the ASD-only group. However, the statistical power was low, and group differences did not remain significant after correction for multiple comparisons, even though effect sizes were moderate to large. No differences in the counts of activated leukocyte populations were observed. Conclusion: These findings raise the possibility that immune system alterations may be associated with EP in children with ASD and could potentially aid diagnosis, although larger studies are needed to confirm these findings.
- 5 January 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 16, 1720712
Open AccessImmune biomarkers for epilepsy in autism: indications of cytokine alterations in an exploratory cross-sectional pediatric study
Background: Children with autism spectrum disorder (ASD) are at increased risk of epilepsy (EP), but distinguishing epileptic seizures from ASD-associated behavior remains a clinical challenge. Although previous studies have reported changes in peripheral immune markers in adults with EP, it remains unclear whether similar immune signatures are present in pediatric patients with both ASD and EP, and more pronounced than in children with ASD alone. Methods: We conducted an exploratory, prospective, cross-sectional study of children aged 9–14 years with mild ASD, with or without EP, recruited from outpatient settings. Peripheral blood samples were analyzed by enzyme-linked immunosorbent assay for 23 immune proteins and by flow cytometry for leukocyte population counts. Analyses included t-tests / Mann–Whitney U-tests, post hoc tests for multiple comparisons, and effect size / power analyses. Results: A total of 30 children were included, n = 21 with primarily mild ASD and n = 9 with mild ASD and EP. The epilepsy cases consisted of children with generalized seizures or self-limited epilepsy with centrotemporal spikes. Three immune proteins, Interleukin (IL)-12p70, IL-13 and IL-1β, were significantly increased in the ASD + EP group compared to the ASD-only group. However, the statistical power was low, and group differences did not remain significant after correction for multiple comparisons, even though effect sizes were moderate to large. No differences in the counts of activated leukocyte populations were observed. Conclusion: These findings raise the possibility that immune system alterations may be associated with EP in children with ASD and could potentially aid diagnosis, although larger studies are needed to confirm these findings.
- Open Access
- 26 February 2023
- Published by Elsevier in Epilepsy Research
- Vol. 191, 107114
Reduced epilepsy development in synapsin 2 knockout mice with autistic behavior following early systemic treatment with interleukin-6 receptor antibody
- 26 February 2023
- Published by Elsevier in Epilepsy Research
- Vol. 191, 107114
Open AccessReduced epilepsy development in synapsin 2 knockout mice with autistic behavior following early systemic treatment with interleukin-6 receptor antibody
- Open Access
Immune response in blood before and after epileptic and psychogenic non-epileptic seizures
- Open Access
- 1 October 2021
- Published by Elsevier in Epilepsy Research
- Vol. 176, 106730
Inflammatory reaction in the retina after focal non-convulsive status epilepticus in mice investigated with high resolution magnetic resonance and diffusion tensor imaging
- 1 October 2021
- Published by Elsevier in Epilepsy Research
- Vol. 176, 106730
Open AccessInflammatory reaction in the retina after focal non-convulsive status epilepticus in mice investigated with high resolution magnetic resonance and diffusion tensor imaging
- Open Access
- 24 February 2021
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 12
Levetiracetam and N-Cadherin Antibody Alleviate Brain Pathology Without Reducing Early Epilepsy Development After Focal Non-convulsive Status Epilepticus in Rats
Focal non-convulsive status epilepticus (fNCSE) is a neurological condition characterized by a prolonged seizure that may lead to the development of epilepsy. Emerging experimental evidence implicates neuronal death, microglial activation and alterations in the excitatory and inhibitory synaptic balance as key features in the pathophysiology following fNCSE. We have previously reported alterations in the excitatory adhesion molecule N-cadherin in rats with fNCSE originating from the hippocampus that subsequently also develop spontaneous seizures. In this study, fNCSE rats were treated intraperitoneally with the conventional anti-epileptic drug levetiracetam in combination with intraparenchymal infusion of N-cadherin antibodies (Ab) for 4 weeks post-fNCSE. The N-cadherin Ab was infused into the fornix and immunohistochemically N-cadherin Ab-stained neurons were detected within the dorsal hippocampal structures as well as in superjacent somatosensory cortex. Continuous levetiracetam treatment for 4 weeks post-fNCSE reduced microglia activation, including cell numbers and morphological changes, partly decreased neuronal cell loss, and excitatory post-synaptic scaffold protein PSD-95 expression in selective hippocampal structures. The additional treatment with N-cadherin Ab did not reverse neuronal loss, but moderately reduced microglial activation, and further reduced PSD-95 levels in the dentate hilus of the hippocampus. Despite the effects on brain pathology within the epileptic focus, neither monotherapy with systemic levetiracetam nor levetiracetam in combination with local N-cadherin Ab administration, reduced the amount of focal or focal evolving into bilateral convulsive seizures, seizure duration, or interictal epileptiform activity during 1 month of continuous electroenephalogram recordings within the hippocampus after fNCSE. Behavioral tests for spatial memory, anxiety, social interaction and anhedonia did not detect gross behavioral differences between fNCSE rats with or without treatment. The results reveal the refractory features of the present rodent model of temporal lobe epilepsy following fNCSE, which supports its clinical value for further therapeutic studies. We identify the persistent development of epilepsy following fNCSE, in spite of partly reduced brain pathology within the epileptic focus.
- 24 February 2021
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 12
Open AccessLevetiracetam and N-Cadherin Antibody Alleviate Brain Pathology Without Reducing Early Epilepsy Development After Focal Non-convulsive Status Epilepticus in Rats
Focal non-convulsive status epilepticus (fNCSE) is a neurological condition characterized by a prolonged seizure that may lead to the development of epilepsy. Emerging experimental evidence implicates neuronal death, microglial activation and alterations in the excitatory and inhibitory synaptic balance as key features in the pathophysiology following fNCSE. We have previously reported alterations in the excitatory adhesion molecule N-cadherin in rats with fNCSE originating from the hippocampus that subsequently also develop spontaneous seizures. In this study, fNCSE rats were treated intraperitoneally with the conventional anti-epileptic drug levetiracetam in combination with intraparenchymal infusion of N-cadherin antibodies (Ab) for 4 weeks post-fNCSE. The N-cadherin Ab was infused into the fornix and immunohistochemically N-cadherin Ab-stained neurons were detected within the dorsal hippocampal structures as well as in superjacent somatosensory cortex. Continuous levetiracetam treatment for 4 weeks post-fNCSE reduced microglia activation, including cell numbers and morphological changes, partly decreased neuronal cell loss, and excitatory post-synaptic scaffold protein PSD-95 expression in selective hippocampal structures. The additional treatment with N-cadherin Ab did not reverse neuronal loss, but moderately reduced microglial activation, and further reduced PSD-95 levels in the dentate hilus of the hippocampus. Despite the effects on brain pathology within the epileptic focus, neither monotherapy with systemic levetiracetam nor levetiracetam in combination with local N-cadherin Ab administration, reduced the amount of focal or focal evolving into bilateral convulsive seizures, seizure duration, or interictal epileptiform activity during 1 month of continuous electroenephalogram recordings within the hippocampus after fNCSE. Behavioral tests for spatial memory, anxiety, social interaction and anhedonia did not detect gross behavioral differences between fNCSE rats with or without treatment. The results reveal the refractory features of the present rodent model of temporal lobe epilepsy following fNCSE, which supports its clinical value for further therapeutic studies. We identify the persistent development of epilepsy following fNCSE, in spite of partly reduced brain pathology within the epileptic focus.
- Open Access
- 16 December 2019
- Published by Springer Nature in Sports Medicine - Open
- Vol. 5 (1) , 1-15
Physical Activity Reduces Epilepsy Incidence: a Retrospective Cohort Study in Swedish Cross-Country Skiers and an Experimental Study in Seizure-Prone Synapsin II Knockout Mice
Background: Epilepsy patients commonly exercise less than the general population. Animal studies indicate beneficial effects of physical activity in established epilepsy, while its effect on the development is currently less known. Methods: Here, we investigated the incidence of epilepsy during 20 years in a cohort of participants from the long-distance Swedish cross-country ski race Vasaloppet (n = 197,685) and compared it to the incidence of non-participating-matched controls included in the Swedish population register (n = 197,684). Individuals diagnosed with diseases such as stroke and epilepsy before entering the race were excluded from both groups. Experimentally, we also determined how physical activity could affect the development of epilepsy in epilepsy-prone synapsin II knockout mice (SynIIKO), with and without free access to a running wheel. Results: We identified up to 40–50% lower incidence of epilepsy in the Vasaloppet participants of all ages before retirement. A lower incidence of epilepsy in Vasaloppet participants was seen regardless of gender, education and occupation level compared to controls. The participants included both elite and recreational skiers, and in a previous survey, they have reported a higher exercise rate than the general Swedish population. Sub-analyses revealed a significantly lower incidence of epilepsy in participants with a faster compared to slower finishing time. Dividing participants according to specified epilepsy diagnoses revealed 40–50% decrease in focal and unspecified epilepsy, respectively, but no differences in generalized epilepsy. Voluntary exercise in seizure-prone SynIIKO mice for 1 month before predicted epilepsy development decreased seizure manifestation from > 70 to 40%. Brain tissue analyses following 1 month of exercise showed increased hippocampal neurogenesis (DCX-positive cells), while microglial (Iba1) and astrocytic activation (GFAP), neuronal Map2, brain-derived neurotrophic factor and its receptor tyrosine receptor kinase B intensity were unaltered. Continued exercise for additionally 2 months after predicted seizure onset in SynIIKO mice resulted in a 5-fold reduction in seizure manifestation (from 90 to 20%), while 2 months of exercise initiated at the time of predicted seizure development gave no seizure relief, suggesting exercise-induced anti-epileptogenic rather than anti-convulsive effect. Conclusion: The clinical study and the experimental findings in mice indicate that physical activity may prevent or delay the development of epilepsy.
- 16 December 2019
- Published by Springer Nature in Sports Medicine - Open
- Vol. 5 (1) , 1-15
Open AccessPhysical Activity Reduces Epilepsy Incidence: a Retrospective Cohort Study in Swedish Cross-Country Skiers and an Experimental Study in Seizure-Prone Synapsin II Knockout Mice
Background: Epilepsy patients commonly exercise less than the general population. Animal studies indicate beneficial effects of physical activity in established epilepsy, while its effect on the development is currently less known. Methods: Here, we investigated the incidence of epilepsy during 20 years in a cohort of participants from the long-distance Swedish cross-country ski race Vasaloppet (n = 197,685) and compared it to the incidence of non-participating-matched controls included in the Swedish population register (n = 197,684). Individuals diagnosed with diseases such as stroke and epilepsy before entering the race were excluded from both groups. Experimentally, we also determined how physical activity could affect the development of epilepsy in epilepsy-prone synapsin II knockout mice (SynIIKO), with and without free access to a running wheel. Results: We identified up to 40–50% lower incidence of epilepsy in the Vasaloppet participants of all ages before retirement. A lower incidence of epilepsy in Vasaloppet participants was seen regardless of gender, education and occupation level compared to controls. The participants included both elite and recreational skiers, and in a previous survey, they have reported a higher exercise rate than the general Swedish population. Sub-analyses revealed a significantly lower incidence of epilepsy in participants with a faster compared to slower finishing time. Dividing participants according to specified epilepsy diagnoses revealed 40–50% decrease in focal and unspecified epilepsy, respectively, but no differences in generalized epilepsy. Voluntary exercise in seizure-prone SynIIKO mice for 1 month before predicted epilepsy development decreased seizure manifestation from > 70 to 40%. Brain tissue analyses following 1 month of exercise showed increased hippocampal neurogenesis (DCX-positive cells), while microglial (Iba1) and astrocytic activation (GFAP), neuronal Map2, brain-derived neurotrophic factor and its receptor tyrosine receptor kinase B intensity were unaltered. Continued exercise for additionally 2 months after predicted seizure onset in SynIIKO mice resulted in a 5-fold reduction in seizure manifestation (from 90 to 20%), while 2 months of exercise initiated at the time of predicted seizure development gave no seizure relief, suggesting exercise-induced anti-epileptogenic rather than anti-convulsive effect. Conclusion: The clinical study and the experimental findings in mice indicate that physical activity may prevent or delay the development of epilepsy.
- Open Access
- 2 July 2019
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 10, 701
Immune Profile in Blood Following Non-convulsive Epileptic Seizures in Rats
Non-convulsive status epilepticus (NCSE) is a prolonged epileptic seizure with subtle symptoms that may delay clinical diagnosis. Emerging experimental evidence shows brain pathology and epilepsy development following NCSE. New diagnostic/prognostic tools are therefore needed for earlier and better stratification of treatment. Here we examined whether NCSE initiates a peripheral immune response in blood serum from rats that experienced electrically-induced NCSE. ELISA analysis showed an acute transient increase in serum protein levels including interleukin-6 6 h post-NCSE, similar to the immune reaction in the brain. At 4 weeks post-NCSE, when 75% of rats subjected to NCSE had also developed spontaneous seizures, several immune proteins were altered. In particular, markers associated with microglia, macrophages and antigen presenting cells, such as CD68, MHCII, and galectin-3, were increased and the T-cell marker CD4 was decreased in serum compared to both non-stimulated controls and NCSE rats without spontaneous seizures, without correlation to interictal epileptiform activity. Analyses of serum following intracerebral injection of lipopolysaccharide (LPS) showed an acute increase in interleukin-6, but at 4 weeks unaltered levels of MHCII and galectin-3, an increase in CD8 and CD11b and a decrease in CD68. None of the increased serum protein levels after NCSE or LPS could be confirmed in spleen tissue. Our data identifies the possibility to detect peripheral changes in serum protein levels following NCSE, which may be related to the development of subsequent spontaneous seizures.
- 2 July 2019
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 10, 701
Open AccessImmune Profile in Blood Following Non-convulsive Epileptic Seizures in Rats
Non-convulsive status epilepticus (NCSE) is a prolonged epileptic seizure with subtle symptoms that may delay clinical diagnosis. Emerging experimental evidence shows brain pathology and epilepsy development following NCSE. New diagnostic/prognostic tools are therefore needed for earlier and better stratification of treatment. Here we examined whether NCSE initiates a peripheral immune response in blood serum from rats that experienced electrically-induced NCSE. ELISA analysis showed an acute transient increase in serum protein levels including interleukin-6 6 h post-NCSE, similar to the immune reaction in the brain. At 4 weeks post-NCSE, when 75% of rats subjected to NCSE had also developed spontaneous seizures, several immune proteins were altered. In particular, markers associated with microglia, macrophages and antigen presenting cells, such as CD68, MHCII, and galectin-3, were increased and the T-cell marker CD4 was decreased in serum compared to both non-stimulated controls and NCSE rats without spontaneous seizures, without correlation to interictal epileptiform activity. Analyses of serum following intracerebral injection of lipopolysaccharide (LPS) showed an acute increase in interleukin-6, but at 4 weeks unaltered levels of MHCII and galectin-3, an increase in CD8 and CD11b and a decrease in CD68. None of the increased serum protein levels after NCSE or LPS could be confirmed in spleen tissue. Our data identifies the possibility to detect peripheral changes in serum protein levels following NCSE, which may be related to the development of subsequent spontaneous seizures.